Research & Teaching at MIT

Andreas Mershin's research has being funded by US government agencies (NSF, DoE, DARPA, NASA), industry (Intel, ROHM, GlaxoSmithKline, QR) and Philanthropic Institutions such as the Prostate Cancer Foundation (USA), the Lindau Nobel Foundation (Germany), the Molecular Frontiers Foundation (Sweden), Epoch Foundation (Taiwan) and the Onassis Foundation (Greece). His extended team of past and present collaborators spans the globe having worked with the J.Craig Venter Institute, NIST, University of Minnessota, Columbia University, Harvard University, Stanford University, Princeton University, Boston Children's Hospital,   Massachusetts General Hospital and the Rhode Island School of Design (USA), Medical Detection Dogs, King's College and GSK (UK), the Evolthon Genome Engineering Challenge at the Weizmann Institute (Israel), NTUA, and U Patras (Greece), the MIT-Wuxi alliance, Fudan U and Jiao Tong U (China),  Nanyang Technological U (Singapore), University of Namibia (Namibia)

He has taught the MIT ESG undergraduate "Hard" Physics class, and the MIT IAP "Making Sense of Scent" open access class.

While his MIT laboratory work has ended in June 2023, he continues to deliver occasional  Executive Education Lectures at the MIT Sloan School of Management. His students tend to be mid/late career national and international industry and government leaders. He teaches custom classes typically based on  the well-known "Lab-to-Market the MIT Way" Executive Education course curriculum he developed and continues to update since 2014.